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Abstract
The acute heart rate response to exercise, i.e., heart rate increase during and heart rate recovery after exercise, has often been 
associated with all-cause and cardiovascular mortality. The long-term response of heart rate to exercise results in favour-
able changes in chronotropic function, including decreased resting and submaximal heart rate as well as increased heart rate 
recovery. Both the acute and long-term heart rate response to exercise have been shown to be heritable. Advances in genetic 
analysis enable researchers to investigate this hereditary component to gain insights in possible molecular mechanisms 
underlying interindividual differences in the heart rate response to exercise. In this review, we comprehensively searched 
candidate gene, linkage, and genome-wide association studies that investigated the heart rate response to exercise. A total of 
ten genes were associated with the acute heart rate response to exercise in candidate gene studies. Only one gene (CHRM2), 
related to heart rate recovery, was replicated in recent genome-wide association studies (GWASs). Additional 17 candidate 
causal genes were identified for heart rate increase and 26 for heart rate recovery in these GWASs. Nine of these genes were 
associated with both acute increase and recovery of the heart rate during exercise. These genes can be broadly categorized into 
four categories: (1) development of the nervous system (CCDC141, PAX2, SOX5, and CAV2); (2) prolongation of neuronal 
life span (SYT10); (3) cardiac development (RNF220 and MCTP2); (4) cardiac rhythm (SCN10A and RGS6). Additional 
10 genes were linked to long-term modification of the heart rate response to exercise, nine with heart rate increase and one 
with heart rate recovery. Follow-up will be essential to get functional insights in how candidate causal genes affect the heart 
rate response to exercise. Future work will be required to translate these findings to preventive and therapeutic applications.
Keywords Heart rate increase · Heart rate recovery · Exercise · Genetics
Introduction
The regulation of resting heart rate is complex; autonomic 
tone, central and peripheral reflexes, hormonal influences, 
and factors intrinsic to the heart are all important determi-
nants [1, 2]. Despite recent developments in the understand-
ing of the complex interplay of the plethora of biological 
mechanisms influencing resting heart rate [3], our under-
standing is still incomplete.
The acute heart rate response to exercise, heart rate 
increase during and heart rate recovery after exercise, offers 
unique insights into cardiac physiology compared to heart 
rate in rest and can therefore be exploited to obtain addi-
tional information on cardiac function [4]. Impaired increase 
of heart rate during exercise (chronotropic incompetence) 
and an attenuated heart rate recovery have been associated 
with all-cause mortality and sudden cardiac death in healthy 
individuals [5–7] and in those with cardiac disease, includ-
ing individuals with heart failure [8] and coronary artery 
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disease [9]. Regular endurance exercise training has been 
proven to shift the cardiac autonomic balance towards vagal 
dominance [10]. The long-term response of heart rate to 
exercise results in favourable changes in chronotropic func-
tion, including decreased resting and submaximal heart rate 
as well as increased heart rate recovery [11].
Both the acute and long-term responses of heart rate to 
exercise have been shown to have a large heritable com-
ponent [12–17]. Development in the understanding of the 
human genome and genetic analysis enables researchers to 
investigate the possible molecular mechanisms underlying 
interindividual differences in the acute and long-term heart 
rate response to exercise [18]. In this review, we summarize 
the current knowledge of the acute and long-term heart rate 
response to exercise, with a focus on the genetic contribu-
tion. In addition, we identify gaps in our knowledge and 
discuss possible future directions that might be of interest 
to enhance the understanding of the heart rate response to 
exercise and consider its potential clinical applications.
Acute response
Heart rate increase
In general, the regulation of the circulatory system during 
exercise involves several adaptations. These adaptations 
include dilatation of resistance vessels in the active mus-
cles, a decrease in vagal outflow to the heart, followed by 
an increase of sympathetic outflow. If exercise is intense, 
the cholinergic fibers to the adrenal medulla are also acti-
vated, resulting in release of epinephrine into the circulation 
[19]. Under normal physiological conditions, this results in 
increased venous return, contractility, and heart rate [20]. In 
turn, ejection fraction increases due to a greater ejection of 
blood at the end of systole and increased diastolic filling of 
the ventricles as the duration of the systole decreases with 
increased heart rate [20].
The increase of heart rate during exercise is for a major 
part attributable to the decrease in vagal tone followed by 
an increase in sympathetic outflow and an increase in levels 
of circulating catecholamines [19]. It has been shown that 
a substantial component of interindividual differences in 
the heart rate increase during exercise is genetically deter-
mined, with heritability estimates ranging from 0.17 to 0.32 
(Table 1) [12, 14, 15]. This suggests that genetic analyses 
may identify novel biological mechanisms involved in the 
regulation of heart rate response to exercise.
Several studies have focussed on identifying genetic 
determinants that explain interindividual differences in 
heart rate increase during exercise. Genes investigated in 
these studies are summarized in Table 2, shown in Fig. 1, 
and are further discussed here. The ACE gene was one of 
the first candidate genes thoroughly investigated for its pos-
sible relationship with the heart rate response to exercise 
[21]. Genetic association studies focusing on the effect 
of the ACE gene on heart rate increase during exercise 
reported many conflicting results [12, 22–25]. Some stud-
ies tested genes for their indirect effect on the sympathetic 
nervous system. One study observed that the NOS3 gene, 
Table 1  Heritability estimates for the acute and long-term effect of exercise on heart rate response
Heritability estimates for the acute and long-term effect of exercise on heart rate response
a Heart rate recovery measured after 180 s
b Heart rate recovery measured after, respectively, 60 and 180 s
c Heart rate recovery measured after 60 s
d 20 weeks during endurance training program at submaximal (50W) levels
Heritability type Heritability Type of exercise Population N Author, year
Acute response: heart rate increase
 Family 0.32 Submaximal treadmill test General population 2053 Ingelsson et al. (2007) [12]
 SNP-based 0.22 Submaximal bicycle General population 58,818 Verweij et al. (2018) [14]
 SNP-based 0.17 Submaximal bicycle General population 66,800 Ramirez J et al. (2018) [15]
Acute response: heart rate recovery
 Familya 0.34 Submaximal treadmill test General population 2053 Ingelsson et al. (2007) [12]
 Twins and  siblingb 0.60 and 0.65 Maximal bicycle General population 491 Nederend et al. (2016) [13]
 SNP-basedc 0.22 Submaximal bicycle General population 58,818 Verweij et al. (2018) [14]
 SNP-basedc 0.12 Submaximal bicycle General population 66,665 Ramirez et al. (2018) [15]
Trainings response: heart rate increase
 Familyd 0.34 Submaximal bicycle General population 481 An et al. (2003) [17]
 Familyd 0.36 Submaximal bicycle Participants with high 
blood pressure
529 Rice et al. (2002) [16]
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CAV2 rs28495552 7:116113744 C/G/0.50 GWAS ↓ 2.80 × 10−11 Sub-
maximal 
bicycle
General Ramirez et al. 
(2018) [15]
CCDC141 rs10497529 2:179839888 A/G/0.04 GWAS ↑ 2.50 × 10−9 Sub-
maximal 
bicycle
General Ramirez et al. 
(2018) [15]






HMGA2 rs1480470 12:66412130 A/G/0.37 GWAS  ↑ 3.40 × 10−08 Sub-
maximal 
bicycle
General Ramirez et al. 
(2018) [15]
MCTP2 rs12906962 15:95312071 C/T/0.32 GWAS  ↓ 3.50 × 10−13 Sub-
maximal 
bicycle
General Ramirez et al. 
(2018) [15]
MCTP2 rs12906962 15:95312071 C/T/0.33 GWAS  ↓ 2.70 × 10−14 Sub-
maximal 
bicycle
General Verweij et al. 
(2018) [14]
NOLAc,d rs6847149 4:111157701 – GWAS  – 2.74 × 10−06 Standard 
Bruce
General Vasan et al. 
(2007) [34]







PAX2 rs11190709 10:102552663 G/A/0.12 GWAS  ↑ 1.30 × 10−11 Sub-
maximal 
bicycle
General Ramirez et al. 
(2018) [15]
POP4 rs12986417 19:30109533 A/G/0.35 GWAS  ↓ 1.00 × 10−9 Sub-
maximal 
bicycle
General Verweij et al. 
(2018) [14]





PPIL1 rs236352 6:36817113 A/G/0.34 GWAS  ↑ 6.40 × 10−10 Sub-
maximal 
bicycle
General Ramirez et al. 
(2018) [15]
2394 Y. J. van de Vegte et al.
1 3
which produces nitric oxide, was associated with heart 
rate increase during exercise [26]. Although nitric oxide is 
mostly known for its vasodilatory effects, it is also thought 
to have a modulating effect on the parasympathetic and 
sympathetic nervous system [27]. GNAS1 was found to 
be associated with heart rate increase during exercise as 
well [28]. This gene encodes the G protein α-subunit that 
influences the sympathetic nervous system as it enables 
the coupling between adenylyl cyclase and β1-adrenergic 
receptors. On the other hand, many studies brought forward 
genes based on their direct involvement in the sympathetic 
nervous system, and associations were found with the 
ADRB1 [29] and ADRB2 [30] genes, which both encode 
for β-adrenergic receptors. Interestingly, many previous 
findings could not be replicated in the Framingham Off-
spring study, which investigated multiple genes instead of 
focusing on a single gene. In this study, associations were 
found with the ADRA1A and ADRA1D [12]. These genes 
encode for α-adrenergic receptors that are mainly involved 
in smooth muscle cell contraction during sympathetic stim-
ulation [12]. However, associations with the ADRB1 and 
ADRB2 genes could not be re-established [12]. 
Genes found to be associated with heart rate increase during exercise are shown in alphabetical order and are then ordered on the year published. 
Variation stands for either an SNP or deletion/insertion mutation. MAF stands for Minor Allele Frequency. Effects of a variant (in- or decrease) 
on heart rate increase during exercise are shown for the Minor Allele. Candidate stands for candidate gene study. GWAS stands for genome-wide 
association study. A hyphen is shown in case information which was not reported
a Results from only one candidate gene study on ACE are shown; largest study was chosen; G allele in case of deletion; in case of insertion ATA 
CAG TCA CTT TTT TTT TTT TTT TGA GAC GGA GTC TCG CTC TGT CGC CC
b Statistics from gene time of exercise interaction are showed
c Standard Bruce protocol is a maximal exercise treadmill test
d Statistics from the generalized estimating equations (GEE) tests are shown; Alleles were not mentioned in this article. None reached genome-
wide significance; however, these were the most suggestive results
e Naughton protocol is a maximal exercise treadmill test










P value Type of 
exercise test
Population Author; year
RGS6 rs17180489 14:72885471 C/G/0.14 GWAS ↑ 2.50 × 10−11 Sub-
maximal 
bicycle
General Verweij et al. 
(2018) [14]
RNF220 rs272564 1:45012273 C/A/0.28 GWAS ↓ 7.40 × 10−12 Sub-
maximal 
bicycle
General Ramirez et al. 
(2018) [15]
RP1L1 rs58065122 8:10526186 A/G/0.42 GWAS ↑ 3.90 × 10−10 Sub-
maximal 
bicycle
General Ramirez et al. 
(2018) [15]
RYR2c,d rs2819770 1:234237045 – GWAS – 3.53 × 10−6 Standard 
Bruce
General Vasan et al. 
(2007) [34]
SCN10A rs7433723 3:38784957 G/A/0.42 GWAS ↓ 4.50 × 10−8 Sub-
maximal 
bicycle
General Ramirez et al. 
(2018) [15]
SNCAIP rs4836027 5:121866990 C/T/0.32 GWAS ↓ 1.70 × 10−15 Sub-
maximal 
bicycle
General Verweij et al. 
(2018) [14]
SNCA1P rs4836027 5:121866990 C/T/0.31 GWAS ↓ 9.90 × 10−21 Sub-
maximal 
bicycle
General Ramirez et al. 
(2018) [15]
SOX5 rs4246224 12:24784139 A/G/0.15 GWAS ↑ 1.80 × 10−14 Sub-
maximal 
bicycle
General Ramirez et al. 
(2018) [15]
SYT10 rs1343676 12:33537387 T/C/0.51 GWAS ↓ 1.50 × 10−11 Sub-
maximal 
bicycle
General Ramirez et al. 
(2018) [15]
TCF4 rs1125313 18:52859261 C/A/0.50 GWAS ↑ 3.90 × 10−9 Sub-
maximal 
bicycle
General Ramirez et al. 
(2018) [15]
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Although these studies were important for laying the 
foundation of our knowledge on the genetic determinants 
of heart rate increase during exercise, they failed to yield 
a comprehensive view by focusing on one or only a few 
genes. The Framingham Offspring study was the first to 
address these issues by conducting an early genetic linkage 
analysis on heart rate increase and recovery. However, not 
one genetic signal reached the appropriate significance level, 
which can possibly be attributed to the relatively low sample 
size of this study (n  = 2982) [12]. In addition, linkage analy-
ses have been shown to be less successful when applied to 
polygenic traits such as heart rate response to exercise [31], 
in part because of their limited power to detect the effect of 
common alleles with modest effects on disease [32].
More recently, genome-wide association studies 
(GWASs) were introduced. GWASs do have the potential 
to detect common alleles with modest effects on disease, 
since this method allows an unbiased and comprehensive 
search across the genome for single nucleotide polymor-
phisms (SNPs) [33]. The first GWAS on heart rate increase 
during exercise found GAR1 and RYR2 genes to be associ-
ated [34]. GAR1 is required for ribosome biogenesis and 
telomere maintenance. However, its specific function and 
how it possibly interacts with heart rate increase during 
exercise is unknown. RYR2 encodes a calcium channel that 
mediates calcium release from the sarcoplasmic reticulum 
into the cytoplasm and is therefore essential in triggering 
cardiac muscle contraction (Table 2, Fig. 1). RYR2 muta-
tions in humans are associated with arrhythmogenic right-
ventricular dysplasia and catecholaminergic polymorphic 
ventricular tachycardia. Interestingly, although caused by 
a different mutation in the RYR2 gene, both diseases are 
known to cause exercise-induced tachycardia [35–37]. 
However, these associations did not reach genome-wide 
significance, which might be due to the low sample size 
(n = 1238) [34].
Fig. 1  Graphical representation of genes (shown in italic) involved in 
acute heart rate increase during exercise grouped by working mecha-
nism (shown in bold). The left and left upper part of the figure shows 
the nervous system. The middle upper part zooms in on a peripheral 
sympathetic neuron and its synapse. The heart is displayed on the 
right; the upper right of the figure shows the aorta with next to it a 
pacemaker cell in the cardiac sinus node. In the middle of the figure, 
below, we zoom in on cardiac tissue and receptors. Adrenergic recep-
tors are shown in red. Sodium, potassium, and calcium channels are 
shown in red, pink, and green, respectively
2396 Y. J. van de Vegte et al.
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Increasing the sample size for GWASs has been simpli-
fied by the development of inexpensive SNP arrays. Two 
GWASs were recently conducted on the acute heart rate 
response to exercise in the same cohort of the UK Biobank 
[14, 15]. The discussion of methodological differences 
between these studies has been published previously [38] 
and is beyond the scope of the current review. However, a 
summary of important differences is necessary to understand 
different genes found between the two studies. One differ-
ence is that the first study by Verweij et al. had a slightly 
lower sample size, since they used only echocardiography 
(ECG) measurements and did not include heart rate meas-
urements derived by the UK Biobank itself. Another differ-
ence is that the study of Verweij et al. applied a more strin-
gent threshold to claim a genome-wide significant level to be 
true (strategy to reduce the risk of type-1 errors) compared 
to the study published later by Ramirez et al. (p < 8.3 × 10−9 
vs p < 5.0 × 10−8, respectively).
Of special interest are three genes that were found to be 
associated with heart rate increase during exercise in both 
studies, which are SNCAIP, MCTP2, and POP4 [14, 15]. 
The exact mechanism of SCNAIP is not known so far; how-
ever, studies in mice have shown that SCNAIP plays a role 
in neuronal degeneration (Table 2, Fig. 1) [39, 40]. POP4 
is involved in the processing of precursor RNAs [41] and in 
the DNA damage response [42], thus preventing accumula-
tion of deleterious mutations and DNA lesions and therefore 
potentially preventing genomic instabilities and carcinogen-
esis and prolonging neuronal life span. The MCTP2 gene is 
more specific to cardiac tissue. A mutation in the MCTP2 
is known to cause left-ventricular outflow tract malforma-
tions in humans, which may alter the pressure within the 
ventricular outflow tract. Baroreceptors are densely located 
in this region and altered blood pressure could therefore 
lead to altered autonomic feedback on heart rate (Table 2, 
Fig. 1) [43]. Several other candidate genes found in these 
studies already provide a biological hypothesis to account 
for the associations with heart rate response to exercise. 
These genes can be broadly categorized into four categories, 
that is: (1) development of the nervous system, including 
the CCDC141 [44, 45], TCF4 [46, 47], PAX2 [48], SOX5 
[49, 50], and CAV2 [51] genes; (2) prolongation of neu-
ronal life span, including the SYT10 [52] gene; (3) cardiac 
development and disease, including RNF220 [53, 54] gene; 
and, finally, (4) genes involved in cardiac rhythm, includ-
ing SCN10A [55] and RGS6 [56, 57]. Of these, CCDC141, 
CAV2, SYT10, RNF220, and SCN10A were more strongly 
associated with heart rate recovery after exercise (Tables 2, 
3) and will be therefore discussed later. TCF4 is involved in 
the initiation of neuronal differentiation. Clinically, a muta-
tion in TCF4 is known to cause Pitt-Hopkins syndrome, a 
severe congenital encephalopathy characterized by intellec-
tual disability, developmental problems, seizures, breathing 
problems, and typical facial features [46, 47]. PAX2 encodes 
paired box gene 2 and is important in the early embryonic 
development as well. It is mostly known for its involvement 
in development of the kidney and urinary tract, since it is 
linked to papillorenal syndrome [58] and focal segmen-
tal glomerulosclerosis [59]. However, downstream target 
effectors of PAX2 have been hypothesized to be involved 
in neuronal development because of their supposed effect 
on the CHARGE syndrome [48]. SOX5 is involved in the 
regulation of chondrogenesis and the development of the 
nervous system [50]. In mice, it was found that loss of SOX5 
resulted in decreased neuronal differentiation and secondary 
migrational abnormalities [49]. Mutations of the SOX5 gene 
in humans are known to cause the Lamb–Shaffer syndrome, 
which is characterized by speech delay, behavioural prob-
lems, and nonspecific dysmorphic features [50]. RGS6 is part 
of the regulation mechanism of the parasympathetic nervous 
system in the heart [56, 57]. It decreases muscarinic type 2 
receptor (M2R) signalling in the sinoatrial node by rapidly 
terminating Gβγ signalling [56, 57]. In mice, it was shown 
that RGS6 knockdown removes the negative regulation of 
Gβγ leading to enhanced G protein-coupled inwardly rectify-
ing potassium channel (GIRK)-induced sinoatrial and atrio-
ventricular node hyperpolarization [56, 57]. It was therefore 
concluded that normal function of RGS6 is important for 
preventing parasympathetic override and severe bradycardia 
[56]. Its involvement in the parasympathetic nervous system 
was recently established in another GWAS in which it was 
found to be associated with heart rate variability [60], which 
is known to reflect parasympathetic activity [61]. Concern-
ing heart rate increase during exercise, normal function of 
RGS6 probably facilitates parasympathetic withdrawal lead-
ing to the possibility to increase heart rate (Fig. 1).
Interestingly, none of the genes investigated in candidate 
gene studies were found to be associated with heart rate 
increase in any of the three GWASs. This is in line with 
the previous work in which early candidate gene studies 
were difficult to replicate [62, 63]. Two genes, HMGA2 and 
PPIL1, shown in Table 2 have not been discussed so far. 
PPIL1 is a gene that was recently found to be associated with 
heart rate variability as well [60]. However, to our knowl-
edge, there is no current biological hypothesis to explain 
the association between PPIL1 or HMGA2 and heart rate 
increase during exercise.
Heart rate recovery
Heart rate recovery is characterized by increased parasym-
pathetic tone followed by sympathetic withdrawal, which 
follows an inversed gradient pattern compared to heart rate 
increase [19]. It was elegantly shown in a dual-blockade 
study that especially parasympathetic reactivation is essen-
tial for interindividual differences in heart rate recovery 
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[64]. However, the exact mechanisms underlying these dif-
ferences remain to be determined. Twin, family, and GWA 
studies estimated the genetic component to interindividual 
differences of heart rate recovery after one minute to range 
between 0.12 and 0.60 (Table 1). Therefore, genetic stud-
ies may yield novel insights into heart rate recovery. All 
genetic determinants investigated for their potential causal 
role in interindividual differences in heart rate recovery are 
summarized in Table 3 and are discussed below. An illustra-
tion of possible causal genes and how they are supposed to 
influence acute heart rate recovery after exercise is shown 
in Fig. 2.
Initially, the same candidate genes were proposed for 
heart rate recovery as for heart rate increase. For example, 
the ACE gene was found to be related to heart rate recov-
ery in one candidate gene study as well [22]. Another study 
found ADRA1B and ADRA2B to be associated with heart rate 
recovery (Table 3) [12]. The association between ADRA2B 
gene and heart rate recovery was also found in another 
candidate gene study [65]. Other studies focused primar-
ily on the parasympathetic nervous system represented by 
the CHRM2 gene. The minor alleles of the rs324640 and 
rs8191992 SNPs found in CHRM2 region were found to be 
associated with a lower heart rate recovery in the general 
population [66] and in patients with a history of myocardial 
infarction [67]. In addition, these minor alleles increased 
chances of death to coronary artery disease in the latter 
group [67].
The problem of biased selection of candidate genes has 
been solved by conducting GWASs as previously stated. 
The first GWAS on the acute heart rate response to exercise 
found heart rate recovery measured 3 min post-exercise to 
be associated with PRKAG2, though this association did not 
reach genome-wide significance. PRKAG2 is involved in the 
regulation of ATP restoration after periods of ATP depletion 
Fig. 2  Graphical representation of genes (shown in italic) involved in 
acute heart rate recovery after exercise grouped by working mecha-
nism (shown in bold). The left and left upper part of the figure shows 
the nervous system. The middle upper part zooms in on a parasym-
pathetic neuron of the vagus nerve (twice) and its synapse. Note that 
although we zoom in on the brain stem (which is the main location of 
parasympathetic nuclei that innervate the vagus nerve), we actually 
show a peripheral parasympathetic neuron of the vagus nerve. The 
heart is displayed on the right; the upper right of the figure shows the 
aorta with next to it a pacemaker cell in the cardiac sinus node. In the 
middle of the figure, below, we zoom in on cardiac tissue and recep-
tors. Cholinergic receptors and enzymes are shown in light blue and 
glutamate receptors in yellow. Sodium and potassium channels are 
shown in red and pink, respectively
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and therefore might influence the return of heart rate to its 
initial state (Table 3, Fig. 2).
As previously mentioned, sample size was drastically 
increased in the two recent studies in the UK Biobank [14, 
15]. Some differences between both studies have been dis-
cussed earlier (i.e., sample size and genome-wide significant 
threshold). Concerning heart rate recovery, it is worth men-
tioning that the phenotype definition was not equal between 
both studies. The study of Ramirez et al. [15] determined 
heart rate recovery traditionally as the difference between 
maximum heart rate and heart rate approximately 1 min after 
cessation of exercise. The study of Verweij et al. defined 
heart rate recovery at five time points, which included the 
differences between maximum heart rate and heart rate after 
50, 40, 30, 20, and 10 s after exercise. This includes heart 
rate recovery at earlier time points (i.e., 10 s), which was 
recently established to be a superior predictor of outcome 
of all-cause mortality and death by coronary artery disease 
[6, 7].
Interestingly, both studies found the previously investi-
gated candidate gene CHRM2 to be associated with heart 
rate recovery [14, 15]. CHRM2 encodes M2R, the main 
muscarinic cholinergic receptor in the heart. This receptor 
is known for both its negative chronotropic and inotropic 
effects after binding with acetylcholine released by post-
ganglionic parasympathetic nerves (Table 3, Fig. 2) [68]. 
The role of the parasympathetic nervous system in interindi-
vidual differences in heart rate recovery is additionally high-
lighted by the ACHE gene that was found in both studies. 
ACHE encodes for acetylcholinesterase, an enzyme which 
breaks down acetylcholine in the synaptic cleft of postgan-
glionic parasympathetic nerves [69]. An increase of acetyl-
cholinesterase would therefore cause an attenuated heart rate 
recovery by decreasing parasympathetic reactivation. Other 
genes that were found in both studies were SYT10, CNTN3, 
PAX2, CAV2, MED13L, RNF220, and NDUFA11 (Table 3, 
Fig. 2). SYT10 encodes a  Ca2+ sensor synaptotagmin 10 that 
triggers IGF-1 exocytosis, which, in turn, protects neurons 
from degeneration. SYT10 might play an important role in 
the regulation of heart rate, as it was found to be associated 
with resting heart rate [3, 23], heart rate increase [15], and 
heart rate variability [60] as well. CNTN3 belongs to a group 
of glycosylphosphatidyl-anchored cell adhesion molecules 
that are mostly found in neurons [70, 71]. Because of its 
similarity with TAG -1, it is thought to have an important 
function in neuronal outgrowth and wiring of the nervous 
system [70–72]. In the study of Ramirez et al. it was found 
that the allele of one SNP decreased heart rate recovery and 
increased CNTN3 expression levels in the nucleus accum-
bens [15]. Since heart rate recovery is mainly influenced 
by the parasympathetic nervous system [64], it was hypoth-
esized that CNTN3 may also be relevant to cardiac para-
sympathetic modulation [15]. However, it is more likely to 
be associated with cardiac sympathetic modulation, since 
morphology of the nucleus accumbens has been shown to 
be correlated with cardiac sympathetic index [73]. PAX2 is 
known to be the first gene to be expressed in the mid- and 
hindbrain during embryonal developments in mice [74] and 
can be found in the hindbrain in the early stages of embryo 
development in humans as well [48]. The hindbrain includes 
the nucleus tractus solitarius, nucleus ambiguous, and dorsal 
nucleus of the vagus, which are known to mainly influence 
cardiac parasympathetic innervation of the heart through 
vagus nerve stimulation [75]. Less is known about CAV2, 
which was found to be associated with heart rate response to 
exercise as well. However, one study pointed out that CAV2 
is necessary for differentiation of dorsal root ganglion cells 
during the early differentiating programs [51]. The func-
tion of MED13L is unclear as well, but knockdown in 
zebrafish caused abnormal neural-crest cell migration [76]. 
This is supported by clinical characteristics in humans with 
MED13L mutations, which can be characterized by intel-
lectual disabilities, developmental delay, and craniofacial 
anomalies [77]. RNF220 functions as an E3 ubiquitin ligase, 
which determines protein target specificity during posttrans-
lational ubiquitination [53]. A possible link with heart rate 
recovery originates from the involvement of RNF220 in the 
canonical WNT signalling cascade. In a knockdown study, 
RNF220 was shown to stabilize β-catenin by interacting 
with ubiquitin-specific peptidase Usp7 [54]. This stabiliz-
ing function is important, because the WNT/β-catenin sig-
nalling pathway is involved in embryonic cardiac develop-
ment [78], the development of cardiac disease [79–81], and 
in cardiac repair [80]. NDUFA11 is an accessory subunit 
of the mitochondrial membrane respiratory chain NADH 
dehydrogenase complex I. In humans, a splice‐site muta-
tion in this gene is known to cause mitochondrial complex I 
deficiency. This can cause a wide range of disorders, includ-
ing encephalocardiomyopathy [82]. Recently, it was shown 
that downregulation of NDUFA11 by small interfering RNA 
reduced ATP production and increased mitochondria reac-
tive oxygen species production in cardiac mitochondria of 
mice [83]. NDUFA11 was found to be associated with heart 
rate variability as well, suggesting that it is an important 
factor in causing differences between individuals’ heart rate 
response [60].
Other candidate genes found in one of the GWASs pro-
vide a biological hypothesis for their possible causal role 
in interindividual differences in heart rate recovery as 
well. These genes include CCDC141, BCL11A, KCNH8, 
ALG10B, GNG11, GRIK2, and NEGR1. CCDC141 is a 
gene that plays a central role in neuronal development 
[44, 45]. In fact, in utero knockdown of CCDC141 in mice 
resulted in impaired radial migration in [44]. The same 
applies to BCL11A, which encodes a C2H2-type zinc-
finger protein that is involved in neuronal development. 
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Studies in mice have shown that slowed migration of 
neurons upon knockdown resulted in microcephaly with 
decreased brain volume [84], particularly affecting the 
limbic system [85]. Within the human brain, it is most 
highly expressed in the caudate nucleus followed by hip-
pocampus [86]. In humans, different de novo heterozy-
gous mutations have been found to cause developmen-
tal disorder with persistence of fetal haemoglobin [85]. 
KCNH8 encodes a voltage-gated potassium channel. It 
is mainly expressed in the central nervous system and is 
involved in the regulation of neuronal excitation (Table 3, 
Fig. 2) [87–89]. ALG10B is involved in potassium regu-
lation, as well, since it is a potassium channel regulator 
that couples to KCNH2. However, it is more involved in 
cardiac tissue than neuronal tissue and is known for its 
influence on heart rhythm. Upon binding with KCNH2, it 
reduces sensitivity to classic proarrhythmic drug block-
ade [90]. GNG11 encodes the γ11 subunit of the hetero-
trimeric G protein complex Gαβγ [91]. GNG11 is just as 
RGS6 thought to be involved in GIRK activation and was 
found to be associated with heart rate variability [60] as 
well. In this study, it was hypothesized that variations in 
this gene lower the availability of the γ11 subunit, thereby 
reducing Gαβγ component-induced GIRK activation 
[60]. This would lead to decreased heart rate variability 
through attenuated response to changes in cardiac vagal 
activity [60]. If true, the same would apply for heart rate 
recovery; decreased response to cardiac vagal reactivation 
after exercise would translate to blunted heart rate recov-
ery. In addition, another mutation in the RGS6 gene in 
humans was shown to decrease susceptibility to the long 
QT syndrome [92]. GRIK2 encodes a glutamate receptor 
that is mostly expressed in the human cerebral and cer-
ebellar cortices [93]. Here, it is involved in neuronal exci-
tation and plays an important role in a variety of normal 
neurophysiologic processes. Neuronal Growth Regulator 
1 (NEGR1) is essential for neuronal morphology and, just 
as CNTN3, has been shown to regulate neurite outgrowth 
(Table 3, Fig. 2) [94]. Perhaps because of this essential 
function, NEGR1 has been associated with many polygen-
etic traits, including body mass index, years of education, 
and physical activity.
Heart rate increase and recovery share a high genetic 
correlation and it is therefore likely that there is overlap 
in genes that were found for both aspects of the heart 
rate response to exercise [14]. SNCAIP, SOX5, RGS6, 
and MCTP2 genes were already discussed for heart rate 
increase during exercise because of their stronger associa-
tion with this phenotype.
BCAT1, CLPB, PRDM6, SKAP, and SERINC2 are also 
shown in Table 3, but have not been discussed yet. To our 
knowledge, these genes could not be linked to heart rate 
recovery after exercise on a biological basis so far.
Long‑term modification of the heart rate 
response to exercise
Heart rate increase
Regular endurance exercise training is known to shift the 
cardiac autonomic balance towards vagal dominance [10] 
and, as a consequence, diminish submaximal heart rate 
when an individual cycles at the same intensity [11]. Large 
interindividual differences were observed for submaximal 
heart rate training response [95] and heritability analysis 
estimated a genetic component ranging between 0.34 and 
0.36 (Table 1) [16, 17]. Therefore, several studies were 
conducted to gain insights in the causes of these interin-
dividual differences. The first study in the HERITAGE 
family cohort found a heritability of 0.34 for exercise heart 
rate changes to regular training, with the strongest linkage 
on chromosome 2q33.3-q34 [17]. Next, this region was 
fine-mapped and it was found that the CREB1 gene locus 
was strongly associated with submaximal exercise heart 
rate training response [96]. Nonetheless, it only explained 
5.45% of the 34% heritability [96].
To gain further insights in the genes causing the remain-
ing fraction of its heritability, a GWAS was performed in the 
HERITAGE family cohort. In this study, nine SNPs were 
identified and accounted for the total of 34% heritability of 
exercise-induced changes to heart rate increase [97]. The 
most significantly associated SNP was linked to the YWHAQ 
gene (Table 4). YWHAQ is mostly expressed in the brain, 
heart, and pancreas [98], and its main function is apoptosis 
and cell proliferation. It was shown that the cardiac-specific 
mutated YWHAQ gene leads to increased pathological ven-
tricular remodelling with increased cardiomyocyte apop-
tosis after experimental myocardial infarction [99]. It can 
be hypothesized that mutations in the YWHAQ gene lead 
to similar pathological cardiac remodelling after exercise 
training, causing diminished exercise-induced changes to 
heart rate increase. However, a neurological causal path-
way cannot be ruled out, since the same mechanism could 
apply to neuronal remodelling needed to attenuate heart rate 
increase after regular exercise training [11].The CREB1 gene 
(Table 4) was significantly associated with submaximal heart 
rate response to exercise training as well [97]. In this study, 
it was hypothesized that CREB1 altered the exercise-induced 
changes in heart rate increase due to its effect on either car-
diac [100] or neuronal memory [101]. Cardiac memory is a 
phenomenon in which an altered T wave on electrocardio-
gram can be seen when sinus rhythm restarts after a period 
of abnormal rhythm, for example, after ventricular pacing 
or arrhythmia [100]. The other hypothesis involving neu-
ronal memory fits in our current understanding that neuron 
biology is of great importance in the heart rate response 
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to exercise. Neuronal memory or long-term potentiation 
is a form of synaptic plasticity in which there is a long-
lasting increase of synaptic strength in case the synapse is 
highly active. It could be hypothesized that regular exercise 
causes an increase of synaptic strength of parasympathetic 
neurons, thus altering the heart rate increase during exer-
cise. However, CREB1 encodes a transcription factor that 
regulates many mechanisms in the body and its association 
with memory does not imply causality. A recent editorial 
rightfully addressed the fact that the same allele in another 
study was found to increase the rise of temperature [102] 
and, therefore, might decrease subjective liking of exercise 
training, potentially diminishing motivation [103].
Table 4  Summary of genes involved in the long-term heart response to exercise
Genes found to be associated with changes in training-induced changes to heart rate increase and recovery are shown in alphabetical order. Vari-
ant stands for either a SNP or deletion/insertion mutation. Candidate stands for candidate gene study. GWAS stands for genome-wide association 
study
a Allele frequencies and betas are not mentioned in this study and direction (in- or decrease of response to training) can, therefore, not be deter-
mined
b Minor alleles of rs324640 and rs8191992 (respectively, A and C) decreased heart rate recovery
Gene Variant Chromosome/
position




 CREB1a rs2253206 2:208100223 1.6 × 10−5  GWAS 20 weeks, 3 









 GCH1a rs2057368 14:54373759 5.6 × 10−5  GWAS 20 weeks, 3 









 GPRIN3a rs1560488 4:90444858 3.3 × 10−5  GWAS 20 weeks, 3 









 RBPMSa rs2979481 8:30382328 3.8 × 10−6  GWAS 20 weeks, 3 









 MYLIPa rs909562 6:16238312 3.2 × 10−5  GWAS 20 weeks, 3 









 OR6N2a rs857838 1:157017174 7.6 × 10−5  GWAS 20 weeks, 3 









 PIWIL1a rs4759659 12:129403241 5.7 × 10−5  GWAS 20 weeks, 3 









 TFECa rs10248479 7:115395591 3.4 × 10−5  GWAS 20 weeks, 3 
times a day, 








 YWHAQa rs6432018 2:9639347 8.1 × 10−7  GWAS 20 weeks, 3 










 CHRM2b  rs324640 7:136146251  0.008 Candidate 2 weeks, 5 times a 
week, 40 min at 
submaximal HR




 CHRM2b  rs8191992  7:136158563  0.005 Candidate 2 weeks, 5 times a 
week, 40 min at 
submaximal HR
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Heart rate recovery
On the other hand, heart rate recovery increases when 
the cardiac autonomic balance shifts towards vagal domi-
nance after regular endurance training [10]. Little research 
has been performed on the genetics of training-induced 
changes to heart rate recovery, although a heritable compo-
nent has been suggested [66]. To our knowledge, only one 
study has been conducted on this subject. In this candidate 
gene study, it was found that the CHRM2 gene (Table 4) is 
linked to long-term modification of heart rate recovery to 
exercise training as well [66]. Participants who had a the 
minor alleles of the rs324640 and rs8191992 SNPs were 
not only found to have a lower acute heart rate recovery, but 
also showed less increase in heart rate recovery after regu-
lar endurance training. As previously mentioned, CHRM2 
encodes the muscarinic acetylcholine receptor M2R and, 
upon activation, causes a negative chronotropic and ino-
tropic response. It therefore seems that genetic variation in 
CHRM2 not only causes interindividual differences in acute 
heart rate recovery [68], but also in long-term modifications. 
A full overview of the genes discussed for the long-term 
heart rate response to exercise can be found in Table 4.
Association of heart rate response 
to exercise‑related genes with other traits
We assessed the association of described genes with other 
traits in publicly available GWASs using the GWAS cata-
logue (Online Resource 1). In short, the candidate causal 
genes that were associated with both heart rate increase 
and recovery were also associated with resting heart rate 
(CCDC141, RGS6, RNF220, SCN10A, and SYT10), heart 
rate variability (CCDC141, RGS6, RNF220, and SYT10), 
blood pressure (CCDC141 and PAX2), atrial fibrillation 
(CAV2 and SCN10A), coronary artery disease (CAV2 and 
SCN10A), and ECG traits including the PR interval (CAV2 
and SCN10A), QRS duration, and the Brugada syndrome 
(both SN10A).
Some genes that were only associated with heart rate 
increase during exercise were found to be associated with 
resting heart rate and heart rate variability (PPIL1), blood 
pressure (ADRB1, ACE, NOS3, and HMGA2), atrial fibril-
lation (MCTP2 and NOS3), exercise treadmill test and 
lung function (both RYR2). Similarly, some of the heart 
rate recovery genes were also associated with resting heart 
rate (ACHE and GNG11), heart rate variability (GNG11 
and NDUFA11), blood pressure (PRDM6, PRKAG2, and 
CHRM2), QRS duration, (PRDM6), atrial fibrillation and 
coronary artery disease (BCL11A, PRDM6), and obesity and 
vigorous physical activity levels (both NEGR1).
Future directions
Improvement of prevention and treatment of disease in the 
human health sector is the ultimate application of novel 
knowledge found by genetic studies and future research 
should be performed to achieve this goal (Fig. 3) [104]. 
Functional follow-up of findings obtained by GWAS will be 
necessary to gain insights in how likely causal genes affect 
the heart rate response to exercise [104]. Most genes that 
were prioritized so far have a plausible biological mecha-
nism in which they influence the heart rate response to 
exercise. However, the exact effect of all genes on exercise-
induced heart rate changes could be validated in an experi-
mental setting (Fig. 3). One possible method is to perform 
functional experiments in cardiomyocytes obtained from 
embryonic stem cells [105]. In cardiomyocytes, human dis-
eases and risk factors with their underlying genetic contribu-
tion can be created in vitro [105]. Since cardiomyocyte cell 
cultures can beat spontaneously [105], simulating the effect 
of this genetic contribution allows for investigation of the 
acute heart rate response to pacing from resting to exercise 
heart rate levels in small cell cultures. In addition, by simu-
lating the effect of this genetic contribution, drugs can be 
screened against an individual’s full genetic backgrounds to 
discover information on cardiotoxicity for each individual. 
This could potentially give insights in the development of 
personalized medicine strategies for heart rate modifica-
tion [106], which is an essential strategy in the treatment 
of coronary artery disease [107] and heart failure (Fig. 3) 
[108, 109]. Genes known to affect cardiac de- and repo-
larisation (RYR2, ALG10B, and SCN10A) or GIRK channels 
in the cardiac sinus node (RGS6 and GNG11) could be of 
interest to study in this setting. Recent development in the 
generation of spinal human cord neural cells could provide 
the same opportunity for investigating neuronal cell lon-
gevity including genes such as SCNAIP, POP4, and SYT10 
[110]. Complex neurological mechanisms at the interplay of 
the sympathetic and parasympathetic nervous system (i.e., 
KCNH8 and GRIK2) or neuronal development (i.e., SOX5, 
PAX2, and BCL11A) are more difficult to investigate using 
this method. This can be solved by investigating these genes 
using in vivo models of animals that share a high percent-
age of their genomic pattern with humans, including mice 
[111, 112], fruit flies [113], and zebrafish [114] (Fig. 3). 
For example, knockdown of RGS6 [56, 57], MED13L [76], 
and BCL11A [85] has already provided insights in biological 
consequences of mutations in these genes.
Improvement of prevention of disease is another goal 
of genetic research. While accurate risk prediction might 
be relatively straightforward for mono- and oligogenic 
disease, this is more difficult for polygenic diseases such 
as coronary artery disease and heart failure. However, the 
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knowledge on genetic variants obtained by GWAS can be 
used to construct genetic risk cores by summing the number 
of risk alleles weighted by the corresponding beta coeffi-
cients. Recently, it was shown that the polygenic risk score 
of coronary artery disease had the ability to identify 8.0% 
of the population at greater than threefold risk for coronary 
artery disease [115]. These individuals can subsequently be 
selected for encouragement of behavioural lifestyle changes 
as relative effects of poor lifestyle were shown to be com-
parable between genetic risk groups [116]. Similar to the 
traditional risk score models in which several traditional 
risk phenotypes are used to predict risk events, this could 
ultimately be performed for genetic risk score models as 
well. As previously stated, there is a large body of obser-
vational studies that links heart rate response to exercise 
to all-cause mortality and cardiovascular disease in healthy 
individuals and those with a history of cardiac disease [5–9]. 
In this light, it would be interesting to see whether adding 
the polygenetic risk scores for the acute heart rate response 
to exercise into a genetic risk score model that includes the 
polygenetic risk score for the cardiovascular disease itself 
could improve detection of individuals at high risk of dis-
ease. However, it should be noted that both recent GWAS on 
the acute heart rate response to exercise did not find support 
for a genetic association with cardiovascular mortality [14, 
15]. The lack of an association in both studies might origi-
nate from the fact that a small replication cohort consisting 
of a relatively young and healthy population was used. The 
study of Verweij et al. [14] did find a significant association 
between heart rate response to exercise and parental age as 
proxy for all-cause mortality. However, first, it is required 
to investigate whether there is a genetic association with 
cardiovascular disease and all-cause mortality, preferably 
in a larger independent cohort [117].
The evidence on long-term modification of the heart rate 
response to exercise is limited so far [97]. If the genetics of 
the acute heart rate response to exercise can be used to predict 
cardiovascular mortality, the combination with information on 
the genetics of the long-term modification of the heart rate 
response to exercise could one day inform the choice of pre-
vention strategy. For example, a high genetic risk score for a 
diminished acute response to exercise combined with a genetic 
Fig. 3  Possible follow-up of GWAS on heart rate response to exer-
cise. Cell models based on pluripotent stem cells provide a potential 
functional model to study GWAS findings using experimental manip-
ulations that cannot be performed in  vivo. Complex mechanisms of 
genetic interplay could be studied in animals that share a high per-
centage of their genomic sequence with humans, including mice, 
fruit flies, and zebrafishes. Tools such as gene knockdowns can be 
used to manipulate the genomes of these animal models. The ultimate 
application of knowledge initiated by GWAS findings in heart rate 
response to exercise lies in the improvement of primary and second-
ary prevention and personalized medicine to improve human health
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risk score that indicates high training-induced changes to heart 
rate response could be an indicator of early primary or second-
ary prevention strategies (Fig. 3). On the other hand, a high 
genetic risk score for a diminished acute response to exercise 
combined with a genetic risk score that indicates little training-
induced changes could be an indication of early intervention 
through medication (Fig. 3).
Conclusion
In the current review, we found a total of 10 genes associ-
ated with the acute heart rate response to exercise in candi-
date gene studies. Only one gene (CHRM2), related to heart 
rate recovery, was replicated in recent GWASs. Additional 17 
candidate causal genes were identified for heart rate increase 
and 26 for heart rate recovery in these GWASs. Nine of these 
genes were associated with both acute heart rate increase and 
recovery during exercise. These genes can be broadly catego-
rized into four categories: (1) development of the nervous sys-
tem (CCDC141, PAX2, SOX5, and CAV2); (2) prolongation of 
neuronal life span (SYT10); (3) cardiac development (RNF220 
and MCTP2), and (4) cardiac rhythm (SCN10A and RGS6). Of 
the total of 43 genes, nine showed overlap with resting heart 
rate and heart rate variability, six with atrial fibrillation and 
coronary artery disease, two with ECG traits, and nine with 
blood pressure. The current findings support the idea that the 
autonomic nervous system is a major player in the regulation 
of the acute heart rate response to exercise. Heart rate recovery 
is especially influenced by parasympathetic nervous system 
genes (ACHE and CHRM2), in line with the previous research 
[64]. Regarding the long-term response to exercise, heart rate 
increase during exercise was found to be mainly associated 
with genes involved in either cardiac or neuronal remodel-
ling. Little evidence has been found for the long-term response 
of heart rate recovery to exercise, except for parasympathetic 
involvement. Future work will be required to translate these 
findings to preventive and therapeutic applications.
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